Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
15
pubmed:dateCreated
2004-10-12
pubmed:abstractText
Inhaled nitric oxide (NO) is a potent and selective pulmonary vasodilator, which induces cGMP synthesis by activating soluble guanylate cyclase (sGC) in ventilated lung regions. Carbon monoxide (CO) has also been proposed to influence smooth muscle tone via activation of sGC. We examined whether direct stimulation of sGC by BAY 41-2272 would produce pulmonary vasodilation and augment the pulmonary responses to inhaled NO or CO.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/15-Hydroxy-11 alpha,9..., http://linkedlifedata.com/resource/pubmed/chemical/3-(4-Amino-5-cyclopropylpyrimidine-2..., http://linkedlifedata.com/resource/pubmed/chemical/Calcium-Binding Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Carbon Dioxide, http://linkedlifedata.com/resource/pubmed/chemical/Carbon Monoxide, http://linkedlifedata.com/resource/pubmed/chemical/Cyclic GMP, http://linkedlifedata.com/resource/pubmed/chemical/Guanylate Cyclase-Activating..., http://linkedlifedata.com/resource/pubmed/chemical/NG-Nitroarginine Methyl Ester, http://linkedlifedata.com/resource/pubmed/chemical/Nitric Oxide, http://linkedlifedata.com/resource/pubmed/chemical/Oxygen, http://linkedlifedata.com/resource/pubmed/chemical/Pyrazoles, http://linkedlifedata.com/resource/pubmed/chemical/Pyridines, http://linkedlifedata.com/resource/pubmed/chemical/Vasodilator Agents
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
1524-4539
pubmed:author
pubmed:issnType
Electronic
pubmed:day
12
pubmed:volume
110
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2253-9
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed-meshheading:15466650-15-Hydroxy-11 alpha,9..., pubmed-meshheading:15466650-Administration, Inhalation, pubmed-meshheading:15466650-Animals, pubmed-meshheading:15466650-Blood Pressure, pubmed-meshheading:15466650-Calcium-Binding Proteins, pubmed-meshheading:15466650-Carbon Dioxide, pubmed-meshheading:15466650-Carbon Monoxide, pubmed-meshheading:15466650-Cyclic GMP, pubmed-meshheading:15466650-Drug Evaluation, Preclinical, pubmed-meshheading:15466650-Drug Interactions, pubmed-meshheading:15466650-Guanylate Cyclase-Activating Proteins, pubmed-meshheading:15466650-Hypertension, Pulmonary, pubmed-meshheading:15466650-Infusions, Intravenous, pubmed-meshheading:15466650-NG-Nitroarginine Methyl Ester, pubmed-meshheading:15466650-Nitric Oxide, pubmed-meshheading:15466650-Oxygen, pubmed-meshheading:15466650-Pulmonary Artery, pubmed-meshheading:15466650-Pyrazoles, pubmed-meshheading:15466650-Pyridines, pubmed-meshheading:15466650-Sheep, pubmed-meshheading:15466650-Vascular Resistance, pubmed-meshheading:15466650-Vasodilator Agents, pubmed-meshheading:15466650-Wakefulness
pubmed:year
2004
pubmed:articleTitle
Soluble guanylate cyclase activator reverses acute pulmonary hypertension and augments the pulmonary vasodilator response to inhaled nitric oxide in awake lambs.
pubmed:affiliation
Department of Anesthesia and Critical Care, Massachusetts General Hospital, Harvard Medical School, 55 Fruit St, CLN 309, Boston, Mass 02114, USA. evgenov@etherdome.mgh.harvard.edu
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural